Annual Accounts Payable
$138.00 K
-$246.40 K-64.10%
01 December 2023
Summary:
Lipella Pharmaceuticals Common Stock annual accounts payable is currently $138.00 thousand, with the most recent change of -$246.40 thousand (-64.10%) on 01 December 2023. During the last 3 years, it has risen by +$113.50 thousand (+463.27%). LIPO annual accounts payable is now -64.10% below its all-time high of $384.40 thousand, reached on 31 December 2022.LIPO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$459.50 K
+$281.10 K+157.57%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock quarterly accounts payable is currently $459.50 thousand, with the most recent change of +$281.10 thousand (+157.57%) on 01 September 2024. Over the past year, it has increased by +$321.50 thousand (+232.97%). LIPO quarterly accounts payable is now at all-time high.LIPO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIPO Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +233.0% |
| 3 y3 years | +463.3% | +879.7% |
| 5 y5 years | - | - |
LIPO Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -64.1% | +463.3% | at high | +1979.2% |
| 5 y | 5 years | -64.1% | +463.3% | at high | +1979.2% |
| alltime | all time | -64.1% | +463.3% | at high | +1979.2% |
Lipella Pharmaceuticals Common Stock Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $459.50 K(+157.6%) |
| June 2024 | - | $178.40 K(-39.3%) |
| Mar 2024 | - | $293.80 K(+112.9%) |
| Dec 2023 | $138.00 K(-64.1%) | $138.00 K(-54.5%) |
| Sept 2023 | - | $303.10 K(+1271.5%) |
| June 2023 | - | $22.10 K(-85.2%) |
| Mar 2023 | - | $148.90 K(-61.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $384.40 K(+719.6%) | $384.40 K(+9.1%) |
| Sept 2022 | - | $352.40 K(+535.0%) |
| June 2022 | - | $55.50 K(-1.8%) |
| Mar 2022 | - | $56.50 K(+20.5%) |
| Dec 2021 | $46.90 K(+91.4%) | - |
| Dec 2021 | - | $46.90 K |
| Dec 2020 | $24.50 K | - |
FAQ
- What is Lipella Pharmaceuticals Common Stock annual accounts payable?
- What is the all time high annual accounts payable for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly accounts payable?
- What is the all time high quarterly accounts payable for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly accounts payable year-on-year change?
What is Lipella Pharmaceuticals Common Stock annual accounts payable?
The current annual accounts payable of LIPO is $138.00 K
What is the all time high annual accounts payable for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high annual accounts payable is $384.40 K
What is Lipella Pharmaceuticals Common Stock quarterly accounts payable?
The current quarterly accounts payable of LIPO is $459.50 K
What is the all time high quarterly accounts payable for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high quarterly accounts payable is $459.50 K
What is Lipella Pharmaceuticals Common Stock quarterly accounts payable year-on-year change?
Over the past year, LIPO quarterly accounts payable has changed by +$321.50 K (+232.97%)